Severity of bleeding Cause of bleeding Site of bleeding (upper or lower gastrointestinal bleeding) Age and general condition of the patient Treatment is initially focused on fluid resuscitation in ...
a Unless otherwise noted, endoscopic treatment was performed. b When two figures are given, the first is for the omeprazole group and the second is for the placebo group. Unless otherwise noted, the ...
DUBLIN--(BUSINESS WIRE)--The "Gastrointestinal Bleeding Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026" report has been added to ...
Gastrointestinal bleeding in GIST patients significantly impacts recurrence-free and overall survival, with gastric bleeding linked to worse prognosis. Bleeding is less common in the small intestine, ...
ALBANY, N.Y, Oct. 15, 2020 /PRNewswire/ -- Set to chart a compound annual growth rate of 4.5% from 2018 to 2026, the global gastrointestinal bleeding treatment market is witnessing creation of a host ...
Gastrointestinal bleeding is common among people with cirrhosis due to a complication called portal hypertension. This is elevated blood pressure in the veins that lead to your liver. Cirrhosis is ...
Both conditions involve symptoms of gastrointestinal bleeding, though a major difference is that hematochezia often presents as bright red blood in the stool, while melena appears as black, tarry ...
Bleeding in ET can range from minor mucocutaneous events to severe hemorrhages, with gastrointestinal bleeding being most common. The JAK2 V617F variant increases bleeding and thrombosis risk, ...
Cavernous haemangiomas are benign vascular lesions that may occur throughout the body, including within the gastrointestinal tract. These lesions comprise dilated blood vessels that can lead to ...
Researchers have identified eight primary factors that increase the risk of a common bleeding complication after heart attack. Some of these factors are already known, but using machine learning ...
Purpose: The etiology, pathophysiology, prognostic factors, pharmacologic treatment, and pharmacoeconomic considerations of nonvariceal upper-gastrointestinal-tract bleeding (UGB) are reviewed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results